Hans Christinger has served as a member of the Advisory Board since 2015. He has served in various roles leading business development and corporate development during his career with Abbott, Roche and Vertex. He brings 24-year bio-pharmaceutical experience, primarily focused on partnering, licensing, and acquisitions (products and companies) as well as divesting products. Christinger has been based both in the U.S. and abroad, and has extensive ex-U.S. experience. He has established and led teams enabling numerous global transactions as well as regional and local deals across more than 30 markets in emerging and developed markets. He began his career as a bench scientist at Genentech where he authored 15 structural biology-related peer-reviewed papers. He earned a Master of Business Administration from Babson College, a Master of Science in Chemistry from San Francisco State University, and a Bachelor of Science in Biochemistry from the University of Vermont.